Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study

Dexamethasone showed mortality benefits in patients with COVID-19. However, the optimal timing for dexamethasone initiation to prevent COVID-19 consequences such as respiratory failure requiring mechanical ventilation (MV) is debatable. As a result, the purpose of this study is to assess the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Korayem, Ghazwa B., Eljaaly, Khalid, Altebainawi, Ali F., Al Harbi, Omar, Badreldin, Hisham A., Al Harthi, Abdullah, Al Yousif, Ghada, Vishwakarma, Ramesh, Albelwi, Shorouq, Almutairi, Rahaf, Almousa, Maha, Alghamdi, Razan, Alhubaishi, Alaa, Alissa, Abdulrahman, Alharbi, Aisha, Algarni, Rahmah, Al Homaid, Sarah, Al Qahtani, Khawla, Akhani, Nada, Al Atassi, Abdulaleam, Al Ghamdi, Ghassan, Aljuhani, Ohoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191551/
https://www.ncbi.nlm.nih.gov/pubmed/35697822
http://dx.doi.org/10.1038/s41598-022-13239-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191551/
https://www.ncbi.nlm.nih.gov/pubmed/35697822
http://dx.doi.org/10.1038/s41598-022-13239-5

Ejemplares similares